Role of platelet-activating factor in pneumolysin-induced acute lung injury
Authors:
- Birgitt GutbierBGBirgitt Gutbier
- John S. OwenJOJohn S. Owen
- Bernd SchmeckBSBernd Schmeck
- Timothy J. MitchellTMTimothy J. Mitchell
- Konstantin MayerKMKonstantin Mayer
- Michael J. ThomasMTMichael J. Thomas
- Satoshi IshiiSISatoshi Ishii
- Simone RosseauSRSimone Rosseau
- Norbert SuttorpNSNorbert Suttorp
- Hartwig SchütteHSHartwig Schütte
- 1 July 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 35 (7) , 1756-1762
Abstract
Objective: Acute respiratory failure is a major complication of severe pneumococcal pneumonia, characterized by impairment of pulmonary microvascular barrier function and pulmonary hypertension. Both features can be evoked by pneumolysin (PLY), an important virulence factor of Streptococcus pneumoniae. We hypothesized that platelet-activating factor (PAF) and associated downstream signaling pathways play a role in the PLY-induced development of acute lung injury. Design: Controlled, ex vivo laboratory study. Subjects: Female Balb/C mice, 8–12 wks old. Interventions: Ventilated and blood-free–perfused lungs of wild-type and PAF receptor–deficient mice were challenged with recombinant PLY. Measurements and Main Results: Intravascular PLY, but not the pneumolysoid Pd-B (PLY with a Trp-Phe substitution at position 433), caused an impressive dose-dependent increase in pulmonary vascular resistance and increased PAF in lung homogenates, as detected by reversed-phase high-performance liquid chromatography coupled to tandem mass spectrometry. The pressor response was reduced in lungs of PAF receptor–deficient mice and after PAF receptor blockade by BN 50730. PLY and exogenous PAF increased thromboxane B2 in lung effluate, and thromboxane receptor inhibition by BM 13505 diminished the pressor response to PLY. Differential inhibition of intracellular signaling steps suggested significant contribution of phosphatidylcholine-specific phospholipase C and protein kinase C and of the Rho/Rho-kinase pathway to PLY-induced pulmonary vasoconstriction. Unrelated to the pulmonary arterial pressor response, microvascular leakage of PLY was diminished in lungs of PAF receptor–deficient mice as well. Conclusions: PAF significantly contributed to PLY-induced acute injury in murine lungs. The PAF-mediated pressor response to PLY depends on thromboxane and on the downstream effectors phosphatidylcholine-specific phospholipase C, protein kinase C, and Rho-kinase.Keywords
This publication has 51 references indexed in Scilit:
- Role of pneumolysin for the development of acute lung injury in pneumococcal pneumoniaCritical Care Medicine, 2006
- Community-acquired pneumoniaThe Lancet, 2003
- Pneumococcal Virulence Factors: Structure and FunctionMicrobiology and Molecular Biology Reviews, 2001
- Protection against Bacteremic Pneumococcal Infection by Antibody to PneumolysinThe Journal of Infectious Diseases, 2001
- Virulence factors and the pathogenesis of disease causedbyResearch in Microbiology, 2000
- Platelet-Activating Factor and Related Lipid MediatorsAnnual Review of Biochemistry, 2000
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Impaired Anaphylactic Responses with Intact Sensitivity to Endotoxin in Mice Lacking a Platelet-activating Factor ReceptorJournal of Experimental Medicine, 1998
- Hyperventilation Induces Release of Cytokines from Perfused Mouse LungAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factorBiochemical Journal, 1997